Co-Authors
This is a "connection" page, showing publications co-authored by Xiaoyang Zhou and Charlie Xiang.
Connection Strength
0.114
-
Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial. Clin Transl Med. 2021 02; 11(2):e297.
Score: 0.058
-
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19. Front Med. 2020 Oct; 14(5):664-673.
Score: 0.056